loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Salmeterol Xinafoate

    Menu

    Salmeterol Xinafoate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 39,700Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 21077 / DOSAGE - POWDER;INHALATION - 0.25MG/INH;EQ 0.05MG BASE/INH

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    FLUTICASONE PROPIONATE(UNII: O2GMZ0LF5W)
    (FLUTICASONE - UNII:CUT2W21N7U)     		FLUTICASONE PROPIONATE500ug | 250ug | 100ug
    SALMETEROL XINAFOATE(UNII: 6EW8Q962A5)
    (SALMETEROL - UNII:2I4BC502BT)     		SALMETEROL50ug | 50ug | 50ug

    Inactive Ingredients

    Ingredient Name
    Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC
    REMEDYREPACK INC.
    A-S Medication Solutions
    Glaxo Operations UK Ltd
    GlaxoSmithKline LLC
    Prasco Laboratories
    Proficient Rx LP
    RPK Pharmaceuticals, Inc.
    LACTOSE(J2B2A4N98G)      
    LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)